Symic is a biotechnology company developing extracellular matrix therapeutics.
Investment Status: Former
Sorrento Therapeutics
Sorrento is a biotechnology company focused on developing treatments for cancer, autoimmune diseases, inflammation, and pain.
Sagimet Biosciences
Sagimet is a biotechnology company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways.
Otonomy, Inc.
Otonomy is a biotechnology company developing innovative therapeutics for diseases and disorders of the ear.
ShockWave medical, Inc.
ShockWave is a medical technology company pioneering intravascular lithotripsy for cardiovascular diseases.
Alumis Inc
Alumis is a biotechnology company focused on targeted therapies for immune‑mediated diseases.
Neuroverse, Inc.
Neuroverse is a medical technology company creating wearable neurotechnology for brain monitoring and cognitive health.
NxThera, Inc./ Francis Medical
NxThera is a medical technology company advancing minimally invasive treatments for men with symptoms arising from benign prostatic hyperplasia (BPH).
Lonestar Heart Inc.
Lonestar Heart is a medical technology company providing cardiovascular and thoracic surgery services.
EndoChoice
EndoChoice is a medical technology company providing infection control products, devices, and services for gastrointestinal treatment.